Polio vaccination coverage and seroprevalence of poliovirus antibodies after the introduction of inactivated poliovirus vaccines for routine immunization in Japan - Satoh, Hiroshi; Tanaka-Taya, Keiko; Shimizu, Hiroyuki; Goto, Akiko; Tanaka, Shizuka; Nakano, Tsuyoshi; Hotta, Chiemi; Okazaki, Terue; Itamochi, Masae; Ito, Miyabi; Okamoto-Nakagawa, Reiko; Yamashita, Yasutaka; et al. (Vaccine, 2019)
Keywords: Age; Allergy and Immunology; Antibodies; Antigens; Children; Combined vaccines; Diphtheria; Enterovirus C; Epidemiology; geometry; Health surveillance; Immunization; Immunoglobulins; Japan; Laboratories; monitoring; Parents; Pertussis; Polio; Poliomyelitis; Public health; risk; Routine immunization; Sabin-derived inactivated poliovirus vaccine; Serology; Seroprevalence; Tetanus; vaccination; Vaccination coverage; Vaccine-associated paralytic poliomyelitis; Vaccines; Whooping cough; Japan; cIPV; DTaP-cIPV; NESVPD; VAPP; GMTs; Polio; sIPV; AFP; CIs; IPV; Seroprevalence; Routine immunization; Vaccination coverage; OPV; DTaP-sIPV; Sabin-derived inactivated poliovirus vaccine; oral poliovirus vaccine; vaccine-associated paralytic poliomyelitis; Sabin-derived inactivated poliovirus vaccine combined with diphtheria-tetanus-acellular pertussis vaccine; geometric mean titers; conventional inactivated poliovirus vaccine; inactivated poliovirus vaccine; conventional inactivated poliovirus vaccine combined with diphtheria-tetanus-acellular pertussis vaccine; National Epidemiological Surveillance of Vaccine-Preventable Diseases; acute flaccid paralysis; confidence intervals